![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, September 14, 2019 12:39:31 AM
re;
The pharmaceutical industry is now developing FDA Class-III Pain Medications that are THC/CBD based and with insignificant
side-effects or addiction.
The best-known marijuana extract is the
psychoactive compound tetrahydrocannabinol,
or THC,
but the plant also contains more than 60 lesser-known compounds
that belong to the same chemical family as THC.
There are now several major companies exploring the medicinal
potential of some of these
chemicals, and
some of the world's largest pharma companies,
including AbbVie (ABBV) and
Valeant Pharmaceuticals (VRX), market products in this drug class.
Proscere Bioscience will be on this radar for manufacturing the extraction processes to produce these special cannabis compounds.
P.S. BAYER MAYBE IN BIDDING TOO.
$SIML
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM